EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY)

CUSIP: 29429X109

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM CL A
Total 13F shares
30,644,910
Share change
+2,713,549
Total reported value
$299,385,000
Put/Call ratio
57%
Price per share
$9.77
Number of holders
79
Value change
+$26,531,660
Number of buys
26
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 29429X109?
CUSIP 29429X109 identifies EPHY - EPIPHANY TECHNOLOGY ACQUISIT - COM CL A in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY) as of Q3 2021

As of 30 Sep 2021, EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,644,910 shares. The largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, ARISTEIA CAPITAL LLC, Linden Advisors LP, CITADEL ADVISORS LLC, HGC Investment Management Inc., Arena Capital Advisors, LLC- CA, Saba Capital Management, L.P., RP Investment Advisors LP, Polar Asset Management Partners Inc., and HBK INVESTMENTS L P. This page lists 79 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.